Skip to main content
ALK-Abelló logo

ALK-Abelló — Investor Relations & Filings

Ticker · ALK ISIN · DK0061802139 LEI · 529900SGCREUZCZ7P020 CO Manufacturing
Open in API
Filings indexed 1,214 across all filing types
Latest filing 2026-06-01 Director's Dealing
Country DK Denmark
Listing CO ALK

About ALK-Abelló

https://www.alk.net

ALK-Abelló is a global, research-driven pharmaceutical company specializing in the prevention, diagnosis, and treatment of allergies. The company is a world leader in allergy immunotherapy (AIT), also known as allergy vaccination, which is a disease-modifying treatment that targets the underlying cause of the allergy rather than just the symptoms. Its portfolio includes a range of allergy treatments and services, with products such as injections, sublingual tablets, and emergency treatments for severe allergic reactions like anaphylaxis. With over a century of experience, ALK-Abelló focuses on developing pharmaceutical products to improve the quality of life for people with allergies globally.

Recent filings

Filing Released Lang Actions
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Director's Dealing Classification · 97% confidence The document is a company announcement reporting the transaction of share options by a member of management (Claus Steensen Sølje) in ALK-Abelló A/S under EU Market Abuse Regulation (article 19). It details the allocation of stock options, quantities, values, dates, and transaction venue. This matches the definition of Director's Dealing (insider transactions by executives).
2026-06-01 Danish
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Director's Dealing Classification · 95% confidence The document is a notification under EU Market Abuse Regulation (EU 596/2014) reporting transactions in company stock by senior management (allocation of share options, reporting of transactions by a board member). This matches the definition of a Director’s Dealing report (insider share transactions by directors).
2026-06-01 Danish
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Director's Dealing Classification · 95% confidence The document is a formal company release reporting transactions by a person discharging managerial responsibility under the Market Abuse Regulation (EU Reg. 596/2014). It details insider share option allocations and volumes for a board member. This matches the definition of Director’s Dealing (insider transactions) filings.
2026-06-01 English
Report on transactions with ALK-Abelló A/S B shares and associated securities by managerial staff
Director's Dealing Classification · 96% confidence The document is a notification of transactions in company shares by managerial staff under Article 19 of the EU Market Abuse Regulation (insider trading disclosures). This matches the definition of Director’s Dealing (insider trades) filings.
2026-06-01 English
ALK upgrades its full-year outlook
Earnings Release Classification · 95% confidence The document is a company announcement from ALK updating its financial expectations for the full year 2026, including revenue and EBIT margin guidance. It mentions the upcoming release of the first quarter financial report and an investor presentation with a live audiocast. The document is short (2574 characters) and primarily serves as a market update and notification of an upcoming earnings release and investor call. It does not contain actual financial statements or detailed financial data itself, nor is it a transcript of the call or presentation. Therefore, it is best classified as an Earnings Release (ER), which is the initial announcement of quarterly/periodical financial results and key highlights. Q1 2026
2026-05-04 Danish
ALK upgrades its full-year outlook
Capital/Financing Update Classification · 95% confidence The document is a company announcement from ALK-Abelló A/S about an upward revision of its full-year 2026 financial expectations, including revenue growth and EBIT margin. It mentions the upcoming release of the Q1 financial report and an investor presentation with a live audiocast. The document is short (3240 characters) and primarily serves as a notification of updated guidance and an invitation to a conference call. It does not contain actual financial statements or detailed financial data. It also references the upcoming quarterly report but does not include it. Therefore, this document is best classified as a Capital/Financing Update (CAP) because it updates investors on financial expectations and related events, rather than being a full financial report or earnings release.
2026-05-04 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.